U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07837765) titled 'Heart tEam Decision-making Assisted by Revaz AI Trial' on Sept. 11.
Brief Summary: Coronary artery disease, the narrowing of the blood vessels that supply the heart, is the leading cause of death worldwide. About 2.4 million Canadian adults live with it. There are three main ways to treat it: opening the narrowed artery with a stent, heart bypass surgery, or medications alone. For many patients the best choice is clear, but for people with complicated disease or multiple health conditions, it can be genuinely difficult to know which treatment will lead to the best outcome. For these complex cases, hospitals bring together a "heart ...